Speakers

Hanna P. Lesch

Chief Technology Officer • Exothera SA

As Chief Technology Officer at Exothera, Belgium, Hanna’s primary responsibilities are technology development and innovation in bioproduction platforms. Hanna has made her whole career in the gene therapy field. Over the years she has been in several directors positions leading research and development at FKD Therapies, Finvector, and Kuopio Center for Gene and Cell Therapy. Her research interest has focused on gene therapy and translational development, including early-stage analytics and the development of scalable, robust manufacturing processes operating under current regulatory guidelines. Her PhD was in Molecular Medicine, obtained from the University of Kuopio. She followed up her PhD with post-doc work at the University of California San Diego UCSD, CA, the USA, and the University of Eastern Finland, Kuopio, Finland. She has several patents related to vector manufacturing. 

Also speaking

Peter Peumans

Chief Technology Officer, Health • imec

Vera Araujo

Senior Director, Business Development • Andelyn Biosciences

Susanne Kintscher

Ph.D., MS&T Lead Lentiviral Vector Manufacturing • Miltenyi Bioindustry

Event Info

Image

Advanced Therapies Investment Summit

Find out more about the Investor Pre-Day taking place 10th September 2024.
Image

2023 Sample Attendee List

Take a look at the sample attendee list for Advanced Therapies Europe 2023 here.